Related Experiment Videos
[Extracorporeal membrane oxygenation, ECMO. Experience with the first 22 cases]
M Sánchez Luna1, J Vázquez Estévez, D Blanco Bravo
1Servicio de Neonatología, H.G.U. Gregorio Marañón, Madrid.
Anales Espanoles De Pediatria
|February 10, 2000
Summary
Extracorporeal membrane oxygenation (ECMO) effectively rescues critically ill neonates when standard treatments fail. Meconium aspiration syndrome shows the best prognosis with ECMO, while cardiac ECMO offers a 40% recovery rate in complex cases.
Area of Science:
- Neonatal critical care
- Cardiopulmonary support
Context:
- Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for neonates with severe respiratory or cardiopulmonary failure unresponsive to conventional therapies.
- This study details the initial experience with 22 neonates treated with ECMO at a specialized unit.
Purpose:
- To evaluate the efficacy and outcomes of ECMO in neonates with respiratory (r-ECMO) and cardiac failure (cardiac ECMO).
- To identify patient characteristics and indications associated with ECMO success.
Summary:
- Eight neonates received veno-venous r-ECMO for respiratory failure, with common indications including congenital diaphragmatic hernia and meconium aspiration syndrome. Five of these patients survived.
- Fourteen neonates underwent veno-arterial cardiac ECMO for ventricular failure post-cardiac surgery. Recovery was achieved in 40% of these complex cases, with mortality often linked to multiorgan failure or neurological prognosis.
Impact:
- ECMO demonstrates significant potential in salvaging critically ill neonates, offering a viable last resort when other treatments are insufficient.
- Meconium aspiration syndrome presents a favorable prognosis under ECMO support.
- Cardiac ECMO, while challenging, provides a crucial therapeutic option for severe ventricular failure, achieving recovery in a substantial proportion of patients.